{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:01:29Z","timestamp":1787022089320,"version":"build-2736575974"},"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T00:00:00Z","timestamp":1631232000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Australian Government Research Training Program Scholarship"},{"name":"National Health and Medical Research Council Senior Research Fellowship","award":["ID 1061041"],"award-info":[{"award-number":["ID 1061041"]}]},{"name":"National Health and Medical Research Council Centre for Research Excellence","award":["ID 1110343"],"award-info":[{"award-number":["ID 1110343"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Myotoxicity is one of the common clinical manifestations of red-bellied black snake (\n                      <jats:italic>Pseudechis porphyriacus<\/jats:italic>\n                      ) envenomation characterised by elevated creatine kinase (CK) concentrations of greater than 1000 U\/L. This study aimed to investigate the occurrence of myotoxicity in patients following envenomation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods\/Principal findings<\/jats:title>\n                    <jats:p>Patient characteristics and serial blood samples (timed venom concentrations and CK concentrations, pre- and post- antivenom) from 114 patients (median age 41, 2-90y; 80 male) were extracted from the Australian Snakebite Project database. Patients were categorised into three groups based on peak CK concentrations [no myotoxicity (&lt;1000 U\/L), mild (1000\u201310,000 U\/L) and severe (&gt;10,000 U\/L)]. The odds of (mild or severe) myotoxicity was lower in patients that received early antivenom (within 6 hours post-bite) compared to those that received late or no antivenom (odd ratio was 0.186; 95% confidence interval, 0.052\u20130.664). A population pharmacokinetic-pharmacodynamic (PKPD) model was developed to describe the relationship between the time course of venom (a mixture of toxins) and effect (elevated CK). In addition, a kinetic-pharmacodynamic (KPD) model was developed to describe the relationship between time course of a theoretical toxin and effect. Model development and parameter estimation was performed using NONMEM v7.3. No single set of parameter values from either the PKPD or KPD models were found that could accurately describe the time course of different levels of severity of myotoxicity. The predicted theoretical toxin half-life from the KPD model was 11 \u00b1 3.9 hours compared to the half-life of venom of 5.3 \u00b1 0.36 hours. This indicates that the putative causative toxin\u2019s concentration-time profile does not parallel that of venom.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Early antivenom administration reduces the incidence of myotoxicity. The venom concentration profile does not appear to be the driver for myotoxicity following envenomation. Additional factors that affect the sensitivity of the patient to snake venom\/toxins must be explored to understand the relationship with myotoxicity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0256653","type":"journal-article","created":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T13:33:50Z","timestamp":1631280830000},"page":"e0256653","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Investigating myotoxicity following Australian red-bellied black snake (Pseudechis porphyriacus) envenomation"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7987-6296","authenticated-orcid":true,"given":"Suchaya","family":"Sanhajariya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B.","family":"Duffull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey K.","family":"Isbister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,9,10]]},"reference":[{"issue":"11","key":"pone.0256653.ref001","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1371\/journal.pmed.0050218","article-title":"The Global Burden of Snakebite: A Literature Analysis and Modelling Based on Regional Estimates of Envenoming and Deaths","volume":"5","author":"A Kasturiratne","year":"2008","journal-title":"PLOS Medicine."},{"issue":"4","key":"pone.0256653.ref002","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3390\/toxins11040193","article-title":"Long-term Effects of Snake Envenoming","volume":"11","author":"S Waiddyanatha","year":"2019","journal-title":"Toxins"},{"issue":"1","key":"pone.0256653.ref003","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0041-0101(98)00125-1","article-title":"Structure\u2013function properties of venom components from Australian elapids","volume":"37","author":"BG Fry","year":"1999","journal-title":"Toxicon"},{"issue":"11\u201312","key":"pone.0256653.ref004","doi-asserted-by":"crossref","first-page":"696","DOI":"10.5694\/j.1326-5377.2010.tb04108.x","article-title":"Clinical effects of red-bellied black snake (Pseudechis porphyriacus) envenoming and correlation with venom concentrations: Australian Snakebite Project (ASP-11).","volume":"193","author":"A Churchman","year":"2010","journal-title":"Medical Journal of Australia"},{"issue":"8","key":"pone.0256653.ref005","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.toxicon.2003.11.005","article-title":"Skeletal muscle degeneration induced by venom phospholipases A2: insights into the mechanisms of local and systemic myotoxicity","volume":"42","author":"JM Guti\u00e9rrez","year":"2003","journal-title":"Toxicon"},{"issue":"4","key":"pone.0256653.ref006","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0041-0101(80)90052-5","article-title":"Purification, from Australian elapid venoms, and properties of phospholipases A which cause myoglobinuria in mice","volume":"18","author":"D Mebs","year":"1980","journal-title":"Toxicon"},{"issue":"12","key":"pone.0256653.ref007","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1097\/00005072-199612000-00006","article-title":"Myotoxic activity of the toxic phospholipase, notexin, from the venom of the Australian tiger snake","volume":"55","author":"RW Dixon","year":"1996","journal-title":"Journal of neuropathology and experimental neurology"},{"issue":"6","key":"pone.0256653.ref008","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1440-1681.1978.tb00714.x","article-title":"Further observations on the pathological responses of rat skeletal muscle to toxins isolated from the venom of the Australian tiger snake, Notechis scutatus scutatus","volume":"5","author":"JB Harris","year":"1978","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"issue":"1","key":"pone.0256653.ref009","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0041-0101(81)90121-5","article-title":"Isolation of a hemolytic, toxic phospholipase from the venom of the Australian red-bellied black snake (Pseudechis porphyriacus).","volume":"19","author":"GT Vaughan","year":"1981","journal-title":"Toxicon"},{"issue":"3","key":"pone.0256653.ref010","doi-asserted-by":"crossref","first-page":"119","DOI":"10.5694\/mja17.00094","article-title":"The Australian Snakebite Project, 2005\u20132015 (ASP-20).","volume":"207","author":"CI Johnston","year":"2017","journal-title":"Medical Journal of Australia"},{"key":"pone.0256653.ref011","first-page":"1","article-title":"Australian snakebite myotoxicity (ASP-23).","volume":"2020","author":"CI Johnston","journal-title":"Clinical Toxicology"},{"issue":"1","key":"pone.0256653.ref012","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1042\/bj2810021","article-title":"Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the \u2018phosphocreatine circuit\u2019 for cellular energy homeostasis","volume":"281","author":"T Wallimann","year":"1992","journal-title":"Biochemical Journal"},{"key":"pone.0256653.ref013","doi-asserted-by":"crossref","first-page":"960363","DOI":"10.1155\/2012\/960363","article-title":"Creatine-kinase- and exercise-related muscle damage implications for muscle performance and recovery","volume":"2012","author":"MF Baird","year":"2012","journal-title":"Journal of nutrition and metabolism"},{"issue":"2","key":"pone.0256653.ref014","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/cc2978","article-title":"Bench-to-bedside review: Rhabdomyolysis\u2013an overview for clinicians","volume":"9","author":"AL Huerta-Alard\u00edn","year":"2005","journal-title":"Critical Care"},{"issue":"5","key":"pone.0256653.ref015","doi-asserted-by":"crossref","first-page":"285","DOI":"10.5694\/j.1326-5377.2010.tb03909.x","article-title":"Changes in serial laboratory test results in snakebite patients: when can we safely exclude envenoming","volume":"193","author":"G Ireland","year":"2010","journal-title":"Medical Journal of Australia"},{"issue":"2","key":"pone.0256653.ref016","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000458640","article-title":"Lymphatic transport of cellular enzymes from muscle into the intravascular compartment","volume":"24","author":"J Lindena","year":"1979","journal-title":"Enzyme"},{"issue":"5","key":"pone.0256653.ref017","first-page":"762","article-title":"Short-term immobilization after eccentric exercise","volume":"35","author":"SP Sayers","year":"2003","journal-title":"Part II: creatine kinase and myoglobin. Medicine and science in sports and exercise"},{"issue":"11","key":"pone.0256653.ref018","doi-asserted-by":"crossref","first-page":"763","DOI":"10.5694\/mja12.11172","article-title":"Snakebite in Australia: a practical approach to diagnosis and treatment.","volume":"199","author":"GK Isbister","year":"2013","journal-title":"Medical Journal of Australia"},{"key":"pone.0256653.ref019","first-page":"1","article-title":"Population pharmacokinetics of Pseudechis porphyriacus (red-bellied black snake) venom in snakebite patients","volume":"2021","author":"S Sanhajariya","journal-title":"Clinical Toxicology"},{"issue":"6","key":"pone.0256653.ref020","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1023\/B:JOPA.0000012998.04442.1f","article-title":"Simultaneous vs. Sequential Analysis for Population PK\/PD Data I","volume":"30","author":"L Zhang","year":"2003","journal-title":"Best-Case Performance. Journal of Pharmacokinetics and Pharmacodynamics"},{"issue":"2","key":"pone.0256653.ref021","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/bcp.14154","article-title":"Kinetic-pharmacodynamic model for drugs with non-linear elimination: Parameterisation matters","volume":"86","author":"QX Ooi","year":"2020","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"2","key":"pone.0256653.ref022","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/15563650.2016.1250903","article-title":"Australian taipan (Oxyuranus spp.) envenoming: clinical effects and potential benefits of early antivenom therapy\u2014Australian Snakebite Project (ASP-25).","volume":"55","author":"CI Johnston","year":"2017","journal-title":"Clinical Toxicology"},{"issue":"5","key":"pone.0256653.ref023","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3109\/15563650.2013.787535","article-title":"Mulga snake (Pseudechis australis) envenoming: A spectrum of myotoxicity, anticoagulant coagulopathy, haemolysis and the role of early antivenom therapy-Australian Snakebite Project (ASP-19).","volume":"51","author":"CI Johnston","year":"2013","journal-title":"Clinical Toxicology"},{"issue":"6","key":"pone.0256653.ref024","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3109\/15563650.2014.914526","article-title":"Pharmacokinetics and pharmacodynamics of the myotoxic venom of Pseudechis australis (mulga snake) in the anesthetised rat","volume":"52","author":"AJ Hart","year":"2014","journal-title":"Clinical Toxicology"},{"issue":"2","key":"pone.0256653.ref025","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3390\/toxins10020073","article-title":"Pharmacokinetics of Snake Venom.","volume":"10","author":"S Sanhajariya","year":"2018","journal-title":"Toxins"},{"issue":"3","key":"pone.0256653.ref026","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3390\/toxins12030188","article-title":"The Influence of the Different Disposition Characteristics of Snake Toxins on the Pharmacokinetics of Snake Venom.","volume":"12","author":"S Sanhajariya","year":"2020","journal-title":"Toxins."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0256653","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T13:34:25Z","timestamp":1631280865000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0256653"}},"subtitle":[],"editor":[{"given":"Jos\u00e9 Mar\u00eda","family":"Guti\u00e9rrez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,9,10]]},"references-count":26,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0256653","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,10]]}}}